CASI Pharmaceuticals Stock (NASDAQ: CASI) stock price, news, charts, stock research, profile.
Open | $2.370 |
Close | - |
Volume / Avg. | 3.961K / 195.379K |
Day Range | 2.300 - 2.430 |
52 Wk Range | 1.850 - 8.480 |
Market Cap | $29.885M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 34 |
Short Interest | 0.93% |
Days to Cover | 1.1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of CASI Pharmaceuticals (NASDAQ: CASI) through any online brokerage.
Other companies in CASI Pharmaceuticals’s space includes: NKGen Biotech (NASDAQ:NKGN), Fortress Biotech (NASDAQ:FBIO), Acurx Pharmaceuticals (NASDAQ:ACXP), OncoCyte (NASDAQ:OCX) and T2 Biosystems (NASDAQ:TTOO).
The latest price target for CASI Pharmaceuticals (NASDAQ: CASI) was reported by HC Wainwright & Co. on Wednesday, November 15, 2023. The analyst firm set a price target for 12.00 expecting CASI to rise to within 12 months (a possible 406.33% upside). 3 analyst firms have reported ratings in the last year.
The stock price for CASI Pharmaceuticals (NASDAQ: CASI) is $2.37 last updated Today at May 1, 2024 at 11:56 AM EDT.
There are no upcoming dividends for CASI Pharmaceuticals.
CASI Pharmaceuticals’s Q1 earnings are confirmed for Wednesday, May 15, 2024.
There is no upcoming split for CASI Pharmaceuticals.
CASI Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.